17:55:48 EDT Fri 19 Jul 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:MCUJF - MEDICURE INC - http://www.medicure.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MCUJF - Qnot subscribed0.74    1.26  0.6904Jul 17Jun 2415 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-06-24 17:01U:MCUJFNews ReleaseMedicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
2024-05-29 08:40U:MCUJFNews ReleaseMedicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
2024-04-23 17:02U:MCUJFNews ReleaseMedicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
2024-04-08 17:02U:MCUJFNews ReleaseMedicure Reports Financial Results for Quarter and Year Ended December 31, 2023
2024-04-04 18:02U:MCUJFNews ReleaseMedicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
2023-12-05 17:02U:MCUJFNews ReleaseMedicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
2023-11-23 17:01U:MCUJFNews ReleaseMedicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
2023-11-21 17:01U:MCUJFNews ReleaseMedicure Reports Financial Results for Quarter Ended September 30, 2023
2023-08-29 18:01U:MCUJFNews ReleaseMedicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
2023-07-28 20:01U:MCUJFNews ReleaseMedicure Reports Financial Results For Quarter Ended June 30, 2023
2023-07-24 19:03U:MCUJFNews ReleaseMedicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023